title: MynxGrip for Closure of Antegrade Puncture After Peripheral Interventions With Same-Day Discharge.
abstract: BACKGROUND
  This was the first prospective study to assess the safety and efficiency of MynxGrip vascular closure device (VCD) in peripheral interventions with antegrade access.
  
  
  RESULTS
  We enrolled 66 consecutive patients from 1 center. All patients were discharged home on the day of procedure and were observed for adverse events at 1 and 30 days of follow-up. No major complications were observed. The rate of minor complications (conversion to manual or mechanical compression) was 7.6%. Postdischarge, 3% of patients experienced minor complications-small abscess, ipsilateral deep vein thrombosis. In 1 patient, a second VCD was deployed after device failure. The derived device failure rate was 5.9%. No patients required hospitalization. No late bleeding and no hematomas >6 cm were noted. The mean time to discharge was 4 hours and 5 minutes.
  
  
  CONCLUSIONS
  The MynxGrip was safe and effective in sealing access sites after antegrade femoral artery puncture with same-day discharge.
authors.affiliation: 1 Center for Cardiovascular Research and Development, American Heart of Poland S.A., Katowice, Poland.
authors.forename: Maciej J
authors.initials: MJ
authors.lastname: Pruski
authors.affiliation: 1 Center for Cardiovascular Research and Development, American Heart of Poland S.A., Katowice, Poland.
authors.forename: Aleksandra M
authors.initials: AM
authors.lastname: Blachut
authors.affiliation: 1 Center for Cardiovascular Research and Development, American Heart of Poland S.A., Katowice, Poland.
authors.forename: Magda
authors.initials: M
authors.lastname: Konkolewska
authors.affiliation: 1 Center for Cardiovascular Research and Development, American Heart of Poland S.A., Katowice, Poland.
authors.forename: Adam
authors.initials: A
authors.lastname: Janas
authors.affiliation: 1 Center for Cardiovascular Research and Development, American Heart of Poland S.A., Katowice, Poland.
authors.forename: Eugeniusz
authors.initials: E
authors.lastname: Hrycek
authors.affiliation: 1 Center for Cardiovascular Research and Development, American Heart of Poland S.A., Katowice, Poland.
authors.forename: Piotr P
authors.initials: PP
authors.lastname: Buszman
authors.affiliation: 2 San Antonio Endovascular and Heart Institute, San Antonio, TX, USA.
authors.forename: Radoslaw S
authors.initials: RS
authors.lastname: Kiesz
mesh_terms: D000368:Aged; D002406:Catheterization, Peripheral / Q000009:adverse effects; D004867:Equipment Design; D004868:Equipment Failure; D005260:Female; D005263:Femoral Artery / Q000000981:diagnostic imaging; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006489:Hemostatic Techniques / Q000009:adverse effects / Q000295:instrumentation*; D006801:Humans; D007902:Length of Stay; D008297:Male; D010351:Patient Discharge; D058729:Peripheral Arterial Disease / Q000000981:diagnostic imaging / Q000628:therapy*; D011044:Poland; D011446:Prospective Studies; D011677:Punctures; D012042:Registries; D013997:Time Factors; D016896:Treatment Outcome; D065506:Vascular Closure Devices
keywords: endovascular procedures; peripheral arterial disease; vascular closure devices